Theralase Anti-Cancer Technology Treats Sixth Patient for Bladder Cancer Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT: TSXV) (TLTFF: OTCQX), a clinical stage pharmaceutical company dedicated to the research and deve...Read More
Theralase Anti-Cancer Technology Used to Treat Fifth Patient for Bladder Cancer Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT: TSXV) (TLTFF: OTC), a leading biotech company focused on the commercialization of medical...Read More
Correcting and Replacing: Theralase Anti-Cancer Technology Used to Treat Fifth Patient for Bladder Cancer Toronto, Ontario (FSCwire) - This press release replaces the press release disseminated January 18, 2018 at 7:00AM ET. The press release contained incorrect information in the first paragraph...Read More
Theralase Optimizes Delivery Schedule of Anti-Cancer Vaccine in Destruction of Brain Cancer Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a biotech company focused on the commercialization of m...Read More
TORONTO, ONTARIO and MUNICH, GERMANY--(Marketwired - Dec. 21, 2017) - TANTALEX Resources Corporation (CSE:TTX)(CSE:TTX.CN)(CNSX:TTX)(FRANKFURT:1T0) ("TANTALEX" or the "Corporation"), announces that it has completed a non-brokered private placement fina...Read More
Theralase Discovers Theralase® Cold Laser Therapy Enhances Cancer Destruction for Standard Cancer Treatments Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading biotech company focused...Read More
Theralase Increases Revenue 12% for 3Q2017 Financial Statements Toronto, Ontario (FSCwire) - Toronto, Ontario – November 29, 2017, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading biotech company focused on t...Read More
Theralase Therapeutic Laser Technology Enhances Cancer Destruction Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading biotech company focused on the commercialization of medical lasers to...Read More
Theralase Anti-Cancer Vaccine Validated in Colorectal Cancer Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading biotech company focused on the commercialization of medical lasers to elimin...Read More
Theralase Demonstrates 24 Months Stability of Second Clinical Batch of Lead Anti-Cancer Drug Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading biotech company focused on the commercializa...Read More
Theralase Discovers New Anti-Cancer Vaccine Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading biotech company focused on the commercialization of medical lasers to eliminate pain and the...Read More
Theralase Researcher Discovers Super Potent Anti-Cancer Drugs Toronto, Ontario (FSCwire) - Theralase Technologies Inc. ("Theralase (R)" or the "Company") (TSXV: TLT) (OTCQX: TLTFF), a leading biotech company focused on the commercialization of medical lasers to eliminate pain and the development...Read More
TORONTO, ONTARIO and MUNICH, GERMANY--(Marketwired - Nov. 9, 2017) - TANTALEX Resources Corporation (CSE:TTX)(CSE:TTX.CN)(CNSX:TTX)(FRANKFURT:1T0) ("TANTALEX" or the "Corporation"), is pleased to announce that they have received the final geophysical maps from the airborne magnet...Read More
Theralase Provides Interim Data Analysis on Anti-Cancer Treatment for First Four Patients Treated First Four Patients Treated with Company's Anti-Cancer Treatment Achieve Pre-Defined Primary, Secondary and Exploratory Outcome Measures Toronto, Ontario (FSCwire) - Theralase Technologies Inc. ("Th...Read More
TORONTO, ONTARIO and MUNICH, GERMANY--(Marketwired - Oct. 18, 2017) - TANTALEX Resources Corporation (CSE:TTX)(CSE:TTX.CN)(CNSX:TTX)(FRANKFURT:1T0) ("TANTALEX" or the "Corporation"), is pleased to announce that the Company has been accepted as a new member to the Tantalum-Ni...Read More
TORONTO, ONTARIO and MUNICH, GERMANY--(Marketwired - Oct. 11, 2017) - TANTALEX Resources Corporation (CSE:TTX)(CSE:TTX.CN)(CNSX:TTX)(FRANKFURT:1T0) ("TANTALEX" or the "Corporation"), is pleased to announce that Nico Scholtz (Pr. Sci. Nat) is joining Tantalex as Vice President, Ex...Read More
TORONTO, ONTARIO and MUNICH, GERMANY--(Marketwired - Oct. 5, 2017) - TANTALEX Resources Corporation (CSE:TTX)(CSE:TTX.CN)(CNSX:TTX)(FRANKFURT:1T0) ("TANTALEX" or the "Corporation"), is pleased to announce the delivery of the preliminary maps and a first interpretation of the airb...Read More
TORONTO, ONTARIO and MUNICH, GERMANY--(Marketwired - Sept. 28, 2017) - TANTALEX Resources Corporation (CSE:TTX)(CSE:TTX.CN)(CNSX:TTX)(FRANKFURT:1T0) ("TANTALEX" or the "Corporation"), is pleased to welcome Mr. Victor Cantore to its Advisory Board. Mr. Cantore has been involved...Read More
TORONTO, ONTARIO and MUNICH, GERMANY--(Marketwired - Sept. 20, 2017) - TANTALEX Resources Corporation (CSE:TTX)(CSE:TTX.CN)(CNSX:TTX)(FRANKFURT:1T0) ("TANTALEX" or the "Corporation"), is pleased to announce that its wholly owned subsidiary, United Materials Congo SARL ("UNITED MA...Read More
... for the Assessment and Development of High Tech Mineral Properties (Including but not Limited to Lithium) in Highly Prospective Regions TORONTO, ONTARIO and MUNICH, GERMANY--(Marketwired - Sept. 19, 2017) - The Buckell-Lithium project is located in the Manono-Kitotolo region...Read More